Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Equity (2016 - 2021)

Syndax Pharmaceuticals (SNDX) has 6 years of Return on Equity data on record, last reported at 0.1% in Q3 2021.

  • For Q3 2021, Return on Equity rose 37.0% year-over-year to 0.1%; the TTM value through Sep 2021 reached 0.1%, up 37.0%, while the annual FY2025 figure was 1.42%, 67.0% down from the prior year.
  • Return on Equity reached 0.1% in Q3 2021 per SNDX's latest filing, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.1% in Q3 2021 and bottomed at 1.52% in Q4 2019.
  • Average Return on Equity over 5 years is 0.77%, with a median of 0.6% recorded in 2017.
  • Peak YoY movement for Return on Equity: tumbled -97bps in 2017, then skyrocketed 115bps in 2020.
  • A 5-year view of Return on Equity shows it stood at 0.6% in 2017, then plummeted by -115bps to 1.29% in 2018, then fell by -18bps to 1.52% in 2019, then surged by 76bps to 0.37% in 2020, then soared by 74bps to 0.1% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.1% in Q3 2021, 0.18% in Q2 2021, and 0.23% in Q1 2021.